Skip to content

Categories: metacurum

  • Metacurum, based on Professor Maréne Landströms research and with Maarten de Château as CEO, is collaborating with the Institute for Cancer Research in London and Professor Johan de Bono.

    MetaCurUm Secures SEK 1 Million Grant for Cancer Treatment

    MetaCurUm AB has received a SEK 1 million grant from the Swedish Innovation Agency Vinnova to advance its therapeutic antibody for prostate cancer toward clinical trials. The Vinnova funds will be used further to validate MetaCurUm's mechanism of action and product. MetaCurUm is collaborating with the Institute of Cancer Research in London and Professor Johan de Bono.

  • Maréne Landström, founder of MetaCurUm Biotech AB, and Maarten de Château, CEO.

    MetaCurUm aims to raise SEK 100 Million - following founder's prestigious Award

    MetaCurUm Biotech AB plans to raise 100 million SEK following founder Maréne Landström being named Sweden's Cancer Researcher of the Year. Their groundbreaking cancer treatment, still in the preclinical phase, aims to halt the TGFβ pathway cancer cells utilize. The Umeå based company is collaborating with international researchers and exploring biomarkers for patient stratification.